- Investing Ideas
- /
- Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
25
Companies which are more than 50% undervalued based on analyst price target.
25 companies
Green Thumb Industries
Market Cap: CA$2.3b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$10.13
7D
-3.6%
1Y
-28.4%
Trulieve Cannabis
Market Cap: CA$1.8b
Operates as a cannabis retailer.
TRUL
CA$9.62
7D
-6.1%
1Y
-41.7%
Cresco Labs
Market Cap: CA$632.1m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.
CL
CA$1.42
7D
-6.6%
1Y
-36.9%
Verano Holdings
Market Cap: CA$564.4m
Operates as a vertically integrated multi-state cannabis operator in the United States.
VRNO
CA$1.56
7D
-1.3%
1Y
-65.6%
High Tide
Market Cap: CA$432.9m
Engages in the cannabis retail business in Canada.
HITI
CA$4.97
7D
-1.6%
1Y
79.4%
Eupraxia Pharmaceuticals
Market Cap: CA$389.0m
A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.
EPRX
CA$7.99
7D
-9.9%
1Y
125.1%
TerrAscend
Market Cap: CA$377.1m
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.
TSND
CA$1.02
7D
-7.3%
1Y
-41.0%
NervGen Pharma
Market Cap: CA$240.3m
A biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.
NGEN
CA$3.28
7D
-8.4%
1Y
27.6%
Theratechnologies
Market Cap: CA$215.6m
A biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe.
TH
CA$4.70
7D
3.3%
1Y
179.8%
Cardiol Therapeutics
Market Cap: CA$126.4m
A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
CRDL
CA$1.51
7D
-1.9%
1Y
-43.9%
Satellos Bioscience
Market Cap: CA$117.1m
A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.
MSCL
CA$0.66
7D
-1.5%
1Y
43.5%
Planet 13 Holdings
Market Cap: CA$96.0m
Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.
PLTH
CA$0.29
7D
1.7%
1Y
-63.6%
Medexus Pharmaceuticals
Market Cap: CA$89.5m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$2.77
7D
-7.4%
1Y
4.5%
TRUBAR
Market Cap: CA$88.4m
Operates as a consumer products company with diversified assets in the plant-based and wellness consumer product categories in Canada.
TRBR
CA$0.82
7D
-2.4%
1Y
41.4%
Vext Science
Market Cap: CA$84.2m
Through its subsidiaries, provides integrated agricultural technology, services, and property management services in the cannabis industry in the United States.
VEXT
CA$0.34
7D
6.3%
1Y
47.8%
Medicenna Therapeutics
Market Cap: CA$80.1m
A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.
MDNA
CA$0.96
7D
-4.0%
1Y
-49.2%
Decibel Cannabis
Market Cap: CA$75.0m
An integrated cannabis company, engages in the cannabis cultivation in Canada.
DB
CA$0.13
7D
4.0%
1Y
136.4%
Sona Nanotech
Market Cap: CA$67.7m
Operates as a nanotechnology life sciences company.
SONA
CA$0.60
7D
-1.6%
1Y
122.2%
Sernova Biotherapeutics
Market Cap: CA$60.8m
Operates as a clinical-stage biotechnology company in Canada.
SVA
CA$0.18
7D
5.7%
1Y
-21.3%
Covalon Technologies
Market Cap: CA$58.4m
Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.
COV
CA$2.13
7D
-3.6%
1Y
-36.4%
ZYUS Life Sciences
Market Cap: CA$47.7m
Manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union.
ZYUS
CA$0.61
7D
-4.7%
1Y
-29.1%
Rubicon Organics
Market Cap: CA$39.6m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.
ROMJ
CA$0.59
7D
1.7%
1Y
34.1%
Microbix Biosystems
Market Cap: CA$35.6m
A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.
MBX
CA$0.26
7D
-3.8%
1Y
-23.9%
Rakovina Therapeutics
Market Cap: CA$8.1m
A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.
RKV
CA$0.39
7D
-6.1%
1Y
-59.5%
Delivra Health Brands
Market Cap: CA$6.3m
Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.
DHB
CA$0.20
7D
0%
1Y
-20.0%